We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03650894
Brief Title: Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

First Submitted : August 27, 2018
First Submitted that Met QC Criteria : August 28, 2018
First Posted : August 29, 2018

Last Update Submitted that Met QC Criteria : December 21, 2022
Last Update Posted : December 23, 2022